Accuray Inc
NASDAQ:ARAY

Watchlist Manager
Accuray Inc Logo
Accuray Inc
NASDAQ:ARAY
Watchlist
Price: 0.8025 USD -2.8% Market Closed
Market Cap: $91m

Net Margin

-4.3%
Current
Declining
by 1.8%
vs 3-y average of -2.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-4.3%
=
Net Income
$-19.3m
/
Revenue
$450.9m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-4.3%
=
Net Income
$-19.3m
/
Revenue
$450.9m

Peer Comparison

Country Company Market Cap Net
Margin
US
Accuray Inc
NASDAQ:ARAY
90.6m USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.5B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
185.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.7B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.6B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
35th
Based on 15 072 companies
35th percentile
-4.3%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Accuray Inc
Glance View

Market Cap
91m USD
Industry
Health Care

Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

ARAY Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-4.3%
=
Net Income
$-19.3m
/
Revenue
$450.9m
What is Accuray Inc's current Net Margin?

The current Net Margin for Accuray Inc is -4.3%, which is below its 3-year median of -2.5%.

How has Net Margin changed over time?

Over the last 3 years, Accuray Inc’s Net Margin has decreased from -2.3% to -4.3%. During this period, it reached a low of -5% on Mar 31, 2024 and a high of 0.1% on Mar 31, 2025.

Back to Top